Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
At the event for industry leaders, President Emmanuel Macron positioned France as a global innovator ready to partner with co…
Rare Disease Day on February 29 offers a chance to show solidarity with the estimated 300 million people living with rare dis…
Designed as a launchpad for innovation, the Global Headquarters and Centre for Research & Development includes seven stories …
CSL’s new Global Headquarters and Centre for R&D recently opened its doors in Melbourne, Australia, in the heart of the city’…
On March 6, McKenzie starts leading CSL, whose life-saving medicines are used in more than 100 countries. He begins his new r…
The just-opened fractionation facility in Victoria can process nine times as much donated human plasma, which the biotech com…
When leaders at CSL Behring set ambitious new targets, they were following in the footsteps of audaciously successful compani…
CSL’s Chief Operating Officer breaks down the simple concept that’s guided him throughout his career.
Americas
Asia Pacific
Middle East
Europe
